Drug Markets/Perfluorohexyloctane

Perfluorohexyloctane

1 NDC across 1 manufacturer|0 Generic,1 Brand

Perfluorohexyloctane is used to treat dry eye syndromes, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on May 18, 2023.

Perfluorohexyloctane is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $263.57 to $263.57 per ML. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$263.57 – $263.57

per ML

7d Activity

1↓0 flat

avg -0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing PERFLUOROHEXYLOCTANE

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
MIEBO 100% EYE DROP
$263.5666
per ML
-0.02%

Frequently Asked Questions

What is Perfluorohexyloctane used to treat?

Perfluorohexyloctane is used to treat dry eye syndromes, per the National Library of Medicine's MED-RT classification.

How many Perfluorohexyloctane products are on the market?

The Perfluorohexyloctane drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Perfluorohexyloctane?

NADAC reference prices for Perfluorohexyloctane range from $263.5666 to $263.5666 per ML.

Which manufacturers make Perfluorohexyloctane?

1 manufacturer lists Perfluorohexyloctane in NADAC. Ranked by number of NDCs, the largest are Bausch & Lomb Incorporated (1).

How has the price of Perfluorohexyloctane changed recently?

Over the past 7 days, 0 Perfluorohexyloctane NDCs rose and 1 fell, with a market-wide average change of -0.0%.